WHO recommends rotavirus vaccine for all children
GENEVA (Reuters) – The World Health Organization recommended on Friday that oral rotavirus vaccines be included in all national immunization programs to avert half a million diarrhoeal deaths and 2 million hospitalizations a year.
Children in Europe and the
The U.N. agency's new global guidance is expected to boost demand for Merck's RotaTeq, GlaxoSmithKline's Rotarix vaccines in Africa and
"This WHO recommendation clears the way for vaccines that will protect children in the developing world from one of the most deadly diseases they face," said Tachi Yamada of the Bill & Melinda Gates Foundation.
Rotavirus is a leading cause of severe gastroenteritis, including vomiting and diarrhea, in infants and young children. The contagious infection kills an estimated 1,600 children under the age of 5 every day, mostly in Africa and
The first vaccine developed to fight rotavirus, sold by Wyeth, was pulled from the market in 1999 after it was linked to a rare, life-threatening type of bowel obstruction known as intussusception.
The Merck and Glaxo vaccines do not have that problem.
The WHO said clinical trials in poor communities in
Trials are continuing in
Developing countries wanting help to distribute the rotavirus vaccine can seek assistance from the Global Alliance for Vaccines and Immunization (GAVI), a Geneva-based international procurer and WHO partner.
GAVI, the WHO and the U.N. children's agency UNICEF are now working to develop "a new accelerated and integrated approach" to tackle rotavirus diarrhea and pneumonia together.
Those two vaccine-preventable diseases account for more than 35 percent of the world's child deaths each year, the vast majority in poor countries, the WHO said.
It also stressed that "there are many causes of diarrhoeal disease," meaning that efforts to improve water quality, sanitation standards and access to rehydration salts must continue despite the expansion of the vaccine.
(Editing by Stephanie Nebehay)